COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
作者信息
Gersh Felice L, O'Keefe James H, Henry Brandon M
机构信息
University of Arizona School of Medicine, Tucson.
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City.
出版信息
Mayo Clin Proc. 2021 Mar;96(3):820-821. doi: 10.1016/j.mayocp.2020.12.021. Epub 2020 Dec 29.
Abstract
摘要
相似文献
1
COVID-19, the Female Immune Advantage, and Cardiovascular Impact.新型冠状病毒肺炎、女性免疫优势与心血管影响
Mayo Clin Proc. 2021 Mar;96(3):820-821. doi: 10.1016/j.mayocp.2020.12.021. Epub 2020 Dec 29.
2
In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.回复——2019冠状病毒病、女性免疫优势及心血管影响
Mayo Clin Proc. 2021 Mar;96(3):821-822. doi: 10.1016/j.mayocp.2020.12.020. Epub 2020 Dec 29.
3
Cardiovascular system in the sars-CoV-2: impact of therapies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中的心血管系统：治疗的影响
J Hypertens. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860.
4
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.心血管疾病与 SARS-CoV-2：宿主免疫反应与病毒直接损伤的作用。
Int J Mol Sci. 2020 Oct 30;21(21):8141. doi: 10.3390/ijms21218141.
5
COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?患有心血管疾病的COVID-19：它能帮助预测预后吗？
Heart Surg Forum. 2020 Nov 30;23(6):E895-E896. doi: 10.1532/hsf.3301.
6
Sex-Biased Vulnerability of the Heart to COVID-19.心脏对新冠病毒的性别差异易感性
Mayo Clin Proc. 2020 Nov;95(11):2332-2335. doi: 10.1016/j.mayocp.2020.09.017. Epub 2020 Sep 18.
7
Heartbeat: cardiovascular health in the time of COVID-19.心跳：新冠疫情下的心血管健康
Heart. 2020 Dec;106(24):1867-1869. doi: 10.1136/heartjnl-2020-318627.
8
Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases.全身内皮功能障碍：新冠病毒病、心血管疾病和代谢性疾病的共同途径。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1401-1402. doi: 10.1016/j.numecd.2020.05.007. Epub 2020 May 18.
9
[Cardiovascular system and COVID-19].[心血管系统与新型冠状病毒肺炎]
Turk Kardiyol Dern Ars. 2020 Oct;48(7):635-639. doi: 10.5543/tkda.2020.65204.
10
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.致编辑的信：大邱广域市新冠肺炎住院患者心血管危险因素及心血管疾病对预后的影响
J Korean Med Sci. 2021 Apr 19;36(15):e113. doi: 10.3346/jkms.2021.36.e113.
引用本文的文献
1
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques.人类和恒河猴补体介导免疫中的性别和物种相关差异。
mBio. 2024 Mar 13;15(3):e0028224. doi: 10.1128/mbio.00282-24. Epub 2024 Feb 22.
2
Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques.人类和恒河猴中补体介导免疫的性别及物种相关差异
bioRxiv. 2023 Oct 25:2023.10.23.563614. doi: 10.1101/2023.10.23.563614.
3
In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.回复——2019冠状病毒病、女性免疫优势及心血管影响
Mayo Clin Proc. 2021 Mar;96(3):821-822. doi: 10.1016/j.mayocp.2020.12.020. Epub 2020 Dec 29.
本文引用的文献
1
Sex-Biased Vulnerability of the Heart to COVID-19.心脏对新冠病毒的性别差异易感性
Mayo Clin Proc. 2020 Nov;95(11):2332-2335. doi: 10.1016/j.mayocp.2020.09.017. Epub 2020 Sep 18.
2
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.雌二醇、孕酮、免疫调节与 COVID-19 结局。
Endocrinology. 2020 Sep 1;161(9). doi: 10.1210/endocr/bqaa127.
3
Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?性别特异性免疫生物学因素以及血管紧张素转换酶2（ACE2）表达的差异能否解释男性新冠病毒疾病（COVID-19）病情更严重及死亡率更高的现象？
Diagnosis (Berl). 2020 Nov 18;7(4):385-386. doi: 10.1515/dx-2020-0054.
4
Sex differences in the metabolic effects of the renin-angiotensin system.肾素-血管紧张素系统代谢作用的性别差异。
Biol Sex Differ. 2019 Jul 1;10(1):31. doi: 10.1186/s13293-019-0247-5.
5
The X chromosome and sex-specific effects in infectious disease susceptibility.X 染色体与传染病易感性中的性别特异性效应。
Hum Genomics. 2019 Jan 8;13(1):2. doi: 10.1186/s40246-018-0185-z.
Zotero 插件